Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TYSABRI for Maternal exposure timing unspecified: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 15 adverse event reports in the FDA FAERS database where TYSABRI was used for Maternal exposure timing unspecified.

Most Reported Side Effects for TYSABRI

Side Effect Reports % Deaths Hosp.
Multiple sclerosis relapse 811 9.9% 8 241
Fatigue 759 9.2% 0 56
Malaise 523 6.4% 1 37
Gait disturbance 445 5.4% 2 32
Multiple sclerosis 443 5.4% 9 57
Memory impairment 422 5.1% 0 26
Headache 368 4.5% 0 34
Drug ineffective 329 4.0% 2 25
Asthenia 328 4.0% 3 49
Fall 324 4.0% 8 99
Nasopharyngitis 310 3.8% 0 14
Urinary tract infection 308 3.8% 12 117
Pain 274 3.3% 1 37
Balance disorder 260 3.2% 1 25
Hypoaesthesia 259 3.2% 0 32

Other Indications for TYSABRI

Multiple sclerosis (7,629) Relapsing-remitting multiple sclerosis (198) Product used for unknown indication (190) Crohn's disease (157) Exposure via father (5)

Other Drugs Used for Maternal exposure timing unspecified

VALPROATE (1,477) ADALIMUMAB (1,280) NATALIZUMAB (492) RITONAVIR (486) EMTRICITABINE\TENOFOVIR DISOPROXIL (333) LOPINAVIR\RITONAVIR (278) DIVALPROEX (254) INTERFERON BETA-1A (245) DIMETHYL (212) ATAZANAVIR (169)

Related Pages

TYSABRI Full Profile All Maternal exposure timing unspecified Drugs TYSABRI Demographics TYSABRI Timeline